GSK plc stock analysis

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, infla

Ticker: GSK
Exchange: NYSE
Sector: Health Care
Industry: Pharmaceuticals

Market evidence and data freshness

The public preview recorded GSK plc at 51.51 USD on 2026-08-26T17:57:58.000Z and marked the quote as delayed. This observation is not a trading signal.

Available price history spans 2021-08-30 through 2026-07-14 across 1222 observations; the listed source is CommonQuant Parquet archive backed by Yahoo Finance delayed data. The history end date differs from the latest quote date.

What should I review before buying GSK plc stock?

Compare valuation with reported financial performance, inspect the price history, and weigh the evidence for and against the investment case. Review the risks and assumptions before making your own decision.

Inside the full analysis

Valuation
Growth
Financial health
Ownership
Research

Sign in to open the full analysis. Paid plans use included reports first, then 50 credits per additional report. Reports outside your included market also cost 50 credits. Credit access lasts 72 hours, including revisits.